Hjortrup A, Svendsen L B, Beck H, Hoffmann J, Schroeder M
Department of Surgical Gastroenterology, Bispebjerg Hospital, Copenhagen, Denmark.
Am J Med. 1989 Jun 9;86(6A):113-5. doi: 10.1016/0002-9343(89)90170-8.
A double-blind, randomized study compared the healing of gastric ulcer during a twice-daily regimen of 2 g sucralfate or 400 mg cimetidine. The patients received the tablets one-half hour before breakfast and one-half hour before bedtime. The study included 76 patients with endoscopically proven gastric ulcer. Patients with ulcers less than 3 cm from the pyloric ring and patients with ulcers less than 3 mm in diameter were excluded from the study. Sixty-four patients completed the study. Healing was endoscopically assessed at four-week intervals for 12 weeks. After four, eight, and 12 weeks, the healing rates for cimetidine were 55, 81, and 94 percent, respectively; the healing rates for sucralfate were 52, 79, and 91 percent, respectively. No statistically significant difference was found between the two regimens. At 12 weeks, the risk of overlooking a difference in favor of one of the two dosage regimens was less than 20 percent. The results suggest that 2 g sucralfate twice daily is as effective in the healing of gastric ulcer as 400 mg cimetidine twice daily.
一项双盲随机研究比较了每日两次服用2克硫糖铝或400毫克西咪替丁时胃溃疡的愈合情况。患者在早餐前半小时和就寝前半小时服用药片。该研究纳入了76例经内镜证实为胃溃疡的患者。距幽门环小于3厘米的溃疡患者以及直径小于3毫米的溃疡患者被排除在研究之外。64例患者完成了研究。在12周内每隔4周通过内镜评估愈合情况。4周、8周和12周后,西咪替丁的愈合率分别为55%、81%和94%;硫糖铝的愈合率分别为52%、79%和91%。两种治疗方案之间未发现统计学上的显著差异。在12周时,忽视有利于两种剂量方案之一的差异的风险小于20%。结果表明,每日两次服用2克硫糖铝在胃溃疡愈合方面与每日两次服用400毫克西咪替丁同样有效。